Influence of patient age and stenosis location on wingspan in-stent restenosis
- PMID: 17989366
- PMCID: PMC8119103
- DOI: 10.3174/ajnr.A0869
Influence of patient age and stenosis location on wingspan in-stent restenosis
Abstract
Background and purpose: Wingspan is a self-expanding, microcatheter-delivered microstent specifically designed for the treatment of symptomatic intracranial atherosclerotic disease. Our aim was to discuss the effect of patient age and lesion location on in-stent restenosis (ISR) rates after percutaneous transluminal angioplasty and stenting (PTAS) with the Wingspan system.
Materials and methods: Clinical and angiographic follow-up results were recorded for all patients from 5 participating institutions. ISR was defined as >50% stenosis within or immediately adjacent (within 5 mm) to the implanted stent and >20% absolute luminal loss. For the present analysis, patients were stratified into younger (</=55 years) and older (>55 years) age groups.
Results: ISR occurred at a rate of 45.2% (14/31) in the younger group and 24.2% (15/62) in the older group (odds ratio, 2.6; 95% confidence interval, 1.03-6.5). In the younger group, ISR occurred after treatment of 13/26 (50%) anterior circulation lesions versus only 1/5 (20%) posterior circulation lesions. In the older group, ISR occurred in 9/29 (31.0%) anterior circulation lesions and 6/33 (18.2%) posterior circulation lesions. In young patients, internal carotid artery lesions (10/17 treated, 58.8%), especially those involving the supraclinoid segment (8/9, 88.9%), were very prone to ISR. When patients of all ages were considered, supraclinoid segment lesions had much higher rates of both ISR (66.6% versus 24.4%) and symptomatic ISR (40% versus 3.9%) in comparison with all other locations.
Conclusion: Post-Wingspan ISR is more common in younger patients. This increased risk can be accounted for by a high prevalence of anterior circulation lesions in this population, specifically those affecting the supraclinoid segment, which are much more prone to ISR and symptomatic ISR than all other lesions.
Figures


Comment in
-
How do we spin wingspan?AJNR Am J Neuroradiol. 2008 Jan;29(1):28-9. doi: 10.3174/ajnr.A0883. Epub 2007 Nov 26. AJNR Am J Neuroradiol. 2008. PMID: 18039751 Free PMC article. No abstract available.
-
Re: Turk et al and the "how do we spin wingspan?" commentary.AJNR Am J Neuroradiol. 2008 Sep;29(8):e69; author reply e70. doi: 10.3174/ajnr.A1084. Epub 2008 Apr 3. AJNR Am J Neuroradiol. 2008. PMID: 18388209 Free PMC article. No abstract available.
-
Intracranial stent restenosis diagnosed on routine duplex follow-up investigation.AJNR Am J Neuroradiol. 2008 Sep;29(8):e65; author reply e66. doi: 10.3174/ajnr.A1080. Epub 2008 Jul 18. AJNR Am J Neuroradiol. 2008. PMID: 18641084 Free PMC article. No abstract available.
References
-
- Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881–87 - PubMed
-
- Levy EI, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007;61:644–51 - PubMed
-
- Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16 - PubMed
-
- Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016–20 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources